Hive Digital Technologies began rebounding Monday after an earnings win and Dell deal to power the Bitcoin miner’s growing AI ...
HIVE Digital Technologies (NASDAQ: HIVE) exceeded expectations with strong Bitcoin production and expanding margins.
In an impressive display of growth, HIVE Blockchain Technologies reported a record revenue driven by a significant increase ...
Shares in HIVE Digital soared over 7.5% on Monday as the Bitcoin miner reported record revenues for its most recent quarter.
Shares of HIVE Digital Technologies rose after the company reported higher second-quarter revenue, driven by gains in digital currency mining revenue. The stock climbed 7%, to $3.52, and is up 14% ...
Analysts are estimating that HIVE Digital Technologies will report an earnings per share (EPS) of $0.01. HIVE Digital ...
HIVE Digital Technologies ( ($TSE:HIVE) ) has issued an update. HIVE Digital Technologies reported a record revenue of $87.3 million for Q2 2025, ...
MT Newswires on MSN
HIVE Digital Reports Q2 Loss as Revenue Surges 285%
HIVE Digital Technologies (HIVE.V), up 3.3% in pre-market trading, Monday reported a second-quarter net loss, but revenue surged and beat estimates. The company reported a second-quarter net loss of ...
Novartis has claimed a first-in-class regulatory approval in the US for oral BTK inhibitor remibrutinib as a second-line treatment for chronic spontaneous urticaria (CSU), also known as chronic hives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback